Petrich Adam M - Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine

基本信息

浏览量：100

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 85 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Application of the Model-Informed Drug Development Paradigm to Datopotamab Deruxtecan Dose Selection for Late-Stage Development

Yasong Lu, Shuang Liang,Ying Hong,Naoyuki Tajima,Kashyap Patel, Hanbin Li, David R. Wada,Jon Greenberg,Adam Petrich,Hong Zebger-Gong,Dale Shuster,Pavan Vaddady

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYno. 1 (2024): 23-28

引用0浏览0WOS引用

A Phase 1-2 Trial of DA-EPOCH-R Plus Ixazomib for MYC-aberrant Lymphoid Malignancies: the DACIPHOR Regimen

Reem Karmali,Carlos Galvez,Mehdi Hamadani,Leo Gordon,Jane Winter,Shuo Ma,Valerie Nelson,Timothy S. Fenske, Nirav N. Shah,Deepa Jagadeesh,Andreas Klein,Irene Helenowski,Ruohui Chen,Xinlei Mi,Adam Petrich,Andrew M. Evens,Barbara Pro

BLOOD ADVANCESno. 7 (2024): 1612-1620

引用0浏览0WOS引用

Supplementary Figure 1 from Akt Inhibitors MK-2206 and Nelfinavir Overcome Mtor Inhibitor Resistance in Diffuse Large B-cell Lymphoma

Adam M. Petrich,Violetta V. Leshchenko, P. K. Kuo,Bing Xia,Venu K. Thirukonda,Netha Ulahannan,Shanisha Gordon, Melissa Fazzari,B. Hilda Ye,Joseph A. Sparano,Samir Parekh

openalex（2023）

引用0浏览0引用

Multicenter Phase 2 Study of Romidepsin Plus Lenalidomide for Previously Untreated Peripheral T-cell Lymphoma

Jia Ruan,Jasmine Zain,Brett Palmer,Borko Jovanovic,Xinlei Mi,Alok Swaroop,Jane N. Winter,Leo I. Gordon,Reem Karmali,Jonathan Moreira,Adam M. Petrich,Barbara Pro

Blood Advancesno. 19 (2023): 5771-5779

引用1浏览0WOS引用

Ibrutinib Maintenance after Frontline Treatment in Patients with Mantle Cell Lymphoma

Reem Karmali,Jeremy S. Abramson,Deborah M. Stephens,Jeffrey Barnes,Jane N. Winter,Shuo Ma,Juehua Gao,Jason Kaplan,Adam M. Petrich,Ephraim Hochberg,Tak Takvorian,Xinlei Mi,Valerie Nelson,Leo I. Gordon,Barbara Pro

BLOOD ADVANCES（2023）

引用0浏览0WOS引用

Supplementary Figure 4 from Akt Inhibitors MK-2206 and Nelfinavir Overcome Mtor Inhibitor Resistance in Diffuse Large B-cell Lymphoma

Adam M. Petrich,Violetta Leshchenko,Pei-Yu Kuo,Bing Xia,Venu K. Thirukonda,Netha Ulahannan,Shanisha Gordon,Melissa J. Fazzari,B. Hilda Ye,Joseph A. Sparano,Samir Parekh

crossref（2023）

引用0浏览0引用

Supplementary Figure 2 from Akt Inhibitors MK-2206 and Nelfinavir Overcome Mtor Inhibitor Resistance in Diffuse Large B-cell Lymphoma

Adam M. Petrich,Violetta Leshchenko,Pei-Yu Kuo,Bing Xia,Venu K. Thirukonda,Netha Ulahannan,Shanisha Gordon,Melissa J. Fazzari,B. Hilda Ye,Joseph A. Sparano,Samir Parekh

openalex（2023）

引用0浏览0引用

Supplementary Figure 3 from Akt Inhibitors MK-2206 and Nelfinavir Overcome Mtor Inhibitor Resistance in Diffuse Large B-cell Lymphoma

Adam M. Petrich,Violetta Leshchenko,Pei-Yu Kuo,Bing Xia,Venu K. Thirukonda,Netha Ulahannan,Shanisha Gordon,Melissa J. Fazzari,B. Hilda Ye,Joseph A. Sparano,Samir Parekh

openalex（2023）

引用0浏览0引用

Selective MCL-1 Inhibitor ABBV-467 is Efficacious in Tumor Models but is Associated with Cardiac Troponin Increases in Patients

Communications Medicineno. 1 (2023)

引用1浏览0WOSNATURE引用

Supplementary Figure 6 from Akt Inhibitors MK-2206 and Nelfinavir Overcome Mtor Inhibitor Resistance in Diffuse Large B-cell Lymphoma

Adam M. Petrich,Violetta Leshchenko,Pei-Yu Kuo,Bing Xia,Venu K. Thirukonda,Netha Ulahannan,Shanisha Gordon,Melissa J. Fazzari,B. Hilda Ye,Joseph A. Sparano,Samir Parekh

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn